» Articles » PMID: 35149891

Desmoplastic Reactions and Epithelial-mesenchymal Transition Proteins in Stages II and III Colorectal Cancer: Association with and Prognostic Value for Disease-free Survival

Overview
Journal Virchows Arch
Date 2022 Feb 12
PMID 35149891
Authors
Affiliations
Soon will be listed here.
Abstract

Recent study has shown that there is a close association of desmoplastic reactions (DRs) with the survival of patient with colorectal cancer (CRC). Here, we examined the correlation of DR classification with disease-free survival and overall survival of CRC. Moreover, we also investigated the association of the histological transition of the DR with the expression of cancer-associated fibroblast (CAF)- and epithelial-mesenchymal transition (EMT)-related proteins in CRC in stages II and III. We examined 157 cases of stage II CRC and 163 cases in stage III. We classified DRs into mature, intermediate, and immature types and examined the correlation of the DR patterns with patient survival. Next, the expression of CAF- and EMT-related markers was examined in CRC samples using immunohistochemistry. In stage II CRC, we found a significant correlation of disease-free survival with DR subtype (immature vs mature) in univariate and multivariate analyses. In stage III CRC, however, such association was not identified. Finally, the DR was closely associated with two EMT-related markers in stages II and III CRC. Our findings suggest that classification of the DR may help to predict patient prognosis in CRC. Furthermore, classification of the DR is correlated with the expression of EMT-related proteins.

Citing Articles

Prognostic scoring system based on indicators reflecting the tumor glandular differentiation and microenvironment for patients with colorectal cancer.

Kobayashi T, Ishida M, Miki H, Yamamoto N, Harino T, Yagyu T Sci Rep. 2024; 14(1):14188.

PMID: 38902294 PMC: 11189912. DOI: 10.1038/s41598-024-65015-2.


Desmoplastic Reaction Associates with Prognosis and Adjuvant Chemotherapy Response in Colorectal Cancer: A Multicenter Retrospective Study.

Hu Q, Wang Y, Yao S, Mao Y, Liu L, Li Z Cancer Res Commun. 2023; 3(6):1057-1066.

PMID: 37377615 PMC: 10269709. DOI: 10.1158/2767-9764.CRC-23-0073.


Prognostic impact of desmoplastic reaction in esophageal squamous cell carcinoma patients with neoadjuvant therapy.

Kouzu K, Kajiwara Y, Tsujimoto H, Mochizuki S, Okamoto K, Shinto E Esophagus. 2023; 20(3):474-483.

PMID: 36917327 DOI: 10.1007/s10388-023-00996-z.


Prognostic impact of tumor microenvironment-related markers in patients with adenocarcinoma of the lung.

Sugai M, Yanagawa N, Shikanai S, Osakabe M, Maemondo M, Saito H Int J Clin Oncol. 2022; 28(2):229-239.

PMID: 36376711 PMC: 9889427. DOI: 10.1007/s10147-022-02271-0.


Differential Expression in the Tumor Microenvironment of mRNAs Closely Associated with Colorectal Cancer Metastasis.

Ito K, Osakabe M, Sugimoto R, Yamada S, Sato A, Uesugi N Ann Surg Oncol. 2022; 30(2):1255-1266.

PMID: 36222933 PMC: 9807483. DOI: 10.1245/s10434-022-12574-1.